DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydrocortisone (Hydrocortisone Topical) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydrocortisone side effects in female

Reported by a physician from Germany on 2012-08-10

Patient: female

Reactions: Cellulitis, C-Reactive Protein Increased, Necrosis, Lymphangitis, Aplastic Anaemia, Skin Necrosis, Empyema, Thermal Burn, White Blood Cell Count Increased

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Methotrexate
    Administration route: Oral
    Start date: 2007-06-19

Hydrocortisone
    Indication: Rheumatoid Arthritis

Humira
    Indication: Rheumatoid Arthritis
    Start date: 2005-12-01
    End date: 2006-12-01

Methotrexate
    Indication: Rheumatoid Arthritis
    Start date: 2005-12-01
    End date: 2006-12-01

Other drugs received by patient: Prednisolone; Etanercept



Possible Hydrocortisone side effects in 14 year old female

Reported by a consumer/non-health professional from United States on 2012-05-24

Patient: 14 year old female, weighing 64.8 kg (142.6 pounds)

Reactions: Depressed Level of Consciousness, Encephalitic Infection, Cerebrovascular Accident, Hypertriglyceridaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-02-18

Pegaspargase
    Dosage: 2500 iu, unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-03-02

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2012-02-06

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-02-11

Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-03-09

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11



Possible Hydrocortisone side effects in 80 year old female

Reported by a physician from Switzerland on 2012-05-14

Patient: 80 year old female

Reactions: Pulmonary Embolism

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lucentis
    End date: 2011-10-20

Lucentis

Lucentis
    Indication: AGE-Related Macular Degeneration
    Start date: 2008-12-08

Hydrocortisone
    Administration route: Oral
    Indication: Temporal Arteritis

Lucentis

Lucentis

Lucentis



Possible Hydrocortisone side effects in 14 year old female

Reported by a consumer/non-health professional from United States on 2012-05-11

Patient: 14 year old female, weighing 64.8 kg (142.6 pounds)

Reactions: Depressed Level of Consciousness, Encephalitic Infection, Cerebrovascular Accident, Hypertriglyceridaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2012-02-06

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-02-18

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-03-02

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-03-09

Pegaspargase
    Dosage: 2500 iu, unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-03-02

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-02-11

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11



Possible Hydrocortisone side effects in 13 year old female

Reported by a consumer/non-health professional from United States on 2012-03-29

Patient: 13 year old female, weighing 64.8 kg (142.6 pounds)

Reactions: Depressed Level of Consciousness, Hypertriglyceridaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Pegaspargase
    Dosage: 2500 iu, unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-02-18

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-02-11

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-11
    End date: 2012-02-18



Possible Hydrocortisone side effects in 18 year old male

Reported by a physician from United States on 2012-02-21

Patient: 18 year old male, weighing 72.0 kg (158.4 pounds)

Reactions: Respiratory Failure, Platelet Count Decreased, Herpes Zoster, Klebsiella Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: ;x1; inth ;x1; inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-29
    End date: 2011-12-29

Methotrexate
    Dosage: ;x1; inth ;x1; inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-13
    End date: 2012-01-13

Prednisone TAB
    Dosage: 20 ug/ m**2; bid; po
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/ m**2; qw; iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-29
    End date: 2012-01-28

Velcade
    Dosage: 1.3 mg/m**2; qd; iv
    Indication: Acute Leukaemia
    Start date: 2011-12-29
    End date: 2011-12-30

Cytarabine
    Dosage: ;x1; inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-29
    End date: 2011-12-29

Oncaspar
    Dosage: 2500 iu/m2; qw; im
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-29
    End date: 2012-01-28

Doxorubicin HCL
    Dosage: 60 mg/ m**2; qd; iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-29
    End date: 2011-12-30

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-29



Possible Hydrocortisone side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-14

Patient: 56 year old female, weighing 82.5 kg (181.5 pounds)

Reactions: Blood Pressure Increased, Asthenopia, Chest Discomfort, Drug Hypersensitivity, Electrocardiogram T Wave Abnormal, Headache, Paraesthesia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Hydrocortisone
    Dosage: 100 mg milligram(s)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Oxaliplatin
    Dosage: 220 mg milligram(s), intravenous drip
    Indication: Chemotherapy
    Start date: 2011-10-12
    End date: 2011-10-12

Granisetron
    Dosage: 2 mg milligram(s), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-21

Granisetron
    Dosage: 2 mg milligram(s), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Oxaliplatin
    Dosage: intravenous drip
    Indication: Chemotherapy
    Start date: 2011-09-21

Oxaliplatin
    Dosage: 220 mg milligram(s), intravenous drip
    Indication: Chemotherapy
    Start date: 2011-10-12
    End date: 2011-10-12

Loratadine
    Dosage: 10 mg milligram(s)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Dexamethasone
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Other drugs received by patient: Acetaminophen; Rosuvastatin; Loperamide HCL; Capecitabine; Metoclopramide



Possible Hydrocortisone side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-11-23

Patient: 57 year old female, weighing 82.5 kg (181.5 pounds)

Reactions: Blood Pressure Increased, Dyspnoea, Chest Discomfort, Wheezing, Electrocardiogram T Wave Abnormal, Infusion Related Reaction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Dexamethasone
    Start date: 2011-10-12
    End date: 2011-10-12

Oxaliplatin
    Dosage: 220 mg;qd
    Start date: 2011-10-12
    End date: 2011-10-12

Loratadine
    Dosage: 10 mg
    Start date: 2011-10-12
    End date: 2011-10-12

Hydrocortisone
    Dosage: 100 mg
    Start date: 2011-10-12
    End date: 2011-10-12

Granisetron
    Dosage: 2 mg
    Start date: 2011-10-12
    End date: 2011-10-12

Other drugs received by patient: Capecitabine



Possible Hydrocortisone side effects in female

Reported by a consumer/non-health professional from Australia on 2011-11-21

Patient: female, weighing 82.5 kg (181.5 pounds)

Reactions: Blood Pressure Increased, Dyspnoea, Chest Discomfort, Electrocardiogram Abnormal, Wheezing

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Dexamethasone
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Loratadine
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Hydrocortisone
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Granisetron
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Oxaliplatin
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-12
    End date: 2011-10-12

Other drugs received by patient: Capecitabine



Possible Hydrocortisone side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2011-11-18

Patient: 61 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Death, Renal Failure, Respiratory Failure, Electrolyte Imbalance, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Furosemide
    Dosage: 40 mg
    Administration route: Oral

Piperacillin and Tazobactam

Norepinephrine Bitartrate
    Indication: Blood Pressure Management

Fluconazole
    Administration route: Oral

Desipramide HCL
    Dosage: 50 mg
    Administration route: Oral

Haloperidol
    Dosage: 20 mg
    Administration route: Oral

Vasopressin
    Indication: Blood Pressure Management

Fentanyl-100
    Indication: Pain

Loperamide HCL
    Administration route: Oral

Hydrocortisone

Cyproheptadine HCL
    Indication: Serotonin Syndrome

Quetiapine
    Dosage: 400 mg
    Administration route: Oral

Trazodone HCL
    Dosage: 200 mg
    Administration route: Oral

Venlafaxine
    Dosage: 150 mg
    Administration route: Oral

Lorazepam
    Dosage: 2 mg
    Administration route: Oral

Risperidone
    Dosage: 5 mg
    Administration route: Oral

Prednisone TAB
    Dosage: 7.5 mg
    Administration route: Oral

Midazolam
    Indication: Anxiety

Budesonide

Dantrolene Sodium
    Indication: Neuroleptic Malignant Syndrome

Mometasone Furoate

Other drugs received by patient: Alendronate Sodium; Levothyroxine Sodium; Sumatriptan; Conjugated Estrogen; Albuterol Sulfate Autohaler; Atorvastatin; Cyclobenzaprine; Celecoxib; Omeprazole; Trimethoprim + Sulfamethoxazole; Hydroxychloroquinine; Hydroxyzine



Possible Hydrocortisone side effects in female

Reported by a physician from United States on 2011-11-09

Patient: female, weighing 81.6 kg (179.5 pounds)

Reactions: Pneumonia Fungal, Pneumonia, Osteomyelitis, Pneumocystis Jiroveci Pneumonia, Zygomycosis, Pneumonia Klebsiella, Respiratory Failure, Diarrhoea, Cytomegalovirus Infection, Ileitis, Fusarium Infection

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Remicade
    Dosage: 1000 mg
    Start date: 2011-09-02

Hydrocortisone
    Indication: Crohn's Disease
    Start date: 2011-09-06
    End date: 2011-09-20

Remicade
    Dosage: 400 mg
    Indication: Crohn's Disease
    Start date: 2011-08-15

Hydrocortisone
    Start date: 2011-08-02

Entocort EC
    Administration route: Oral
    Indication: Crohn's Disease
    Start date: 2011-07-01
    End date: 2011-09-06

Remicade
    Dosage: 400 mg
    Start date: 2011-07-25



Possible Hydrocortisone side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-04

Patient: 50 year old female

Reactions: Anoxia, Hypersensitivity, Hyperhidrosis, Renal Ischaemia, Palpitations, Pulmonary Oedema, Myocarditis, Adrenal Mass, Respiratory Rate Increased, Chest Discomfort, Pneumonia, Metabolic Acidosis, Respiratory Distress, Glycogen Storage Disorder, Respiratory Acidosis, Renal Tubular Necrosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Hydrocortisone

Other drugs received by patient: Metoprolol Succinate; Amlodipine



Possible Hydrocortisone side effects in female

Reported by a physician from United States on 2011-11-02

Patient: female, weighing 81.6 kg (179.5 pounds)

Reactions: Pneumonia Fungal, Pneumonia, Osteomyelitis, Pneumocystis Jiroveci Pneumonia, Zygomycosis, Pneumonia Klebsiella, Diarrhoea, Cytomegalovirus Infection, Fusarium Infection

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Remicade
    Dosage: 400 mg
    Indication: Crohn's Disease
    Start date: 2011-08-15

Hydrocortisone
    Start date: 2011-08-02

Remicade
    Dosage: 400 mg
    Start date: 2011-07-25

Hydrocortisone
    Indication: Crohn's Disease
    Start date: 2011-09-06
    End date: 2011-09-20

Entocort EC
    Administration route: Oral
    Indication: Crohn's Disease
    Start date: 2011-07-01
    End date: 2011-09-06

Remicade
    Dosage: 1000 mg
    Start date: 2011-09-02

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017